Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Avery Dennison, 3M Settle Patent And Antitrust Litigation - Quick Facts

RELATED NEWS
Trade AVY now with 

Avery Dennison Corp. (AVY: Quote) announced the settlement of its patent and antitrust litigation with 3M company. Avery said the company will continue to sell its OmniCube products worldwide.

The litigation began when 3M alleged that Avery Dennison infringed its patents and sought a preliminary injunction to prevent Avery from selling OmniCube, a Type XI sheeting product used to increase nighttime visibility of road signs and other highway and transportation products. The court denied 3M's request, and after Avery Dennison brought claims of its own for patent infringement and antitrust violations, the companies agreed to dismiss all three pending cases.

Click here to receive FREE breaking news email alerts for Avery Dennison Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After initially showing a lack of direction, stocks have moved sharply lower over the course of the trading day on Thursday. The losses on the day are extending a recent downward trend by the markets, with the major averages falling to their lowest levels in over a month. After reporting a sharp jump in new orders for U.S. manufactured goods in the previous month, the Commerce Department released a report on Thursday showing that factory orders pulled back by a little more than expected in the month of August. First-time claims for U.S. unemployment benefits unexpectedly decreased in the week ended September 27th, according to a report released by the Labor Department on Thursday. The report said initial jobless claims fell to 287,000, a decrease of 8,000 from the previous week's revised level of 295,000.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.